Home › Migraine › Virginia
Migraine clinical trials in Virginia
6 studies for Migraine are looking for participants at sites in Virginia.
Cities in Virginia
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- and 2 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- and 2 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
- Children's Hospital of The King's Daughters - Children's Medical Tower /ID# 230581, Norfolk
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Health Research of Hampton Roads, Inc. (HRHR), Newport News
- AMR Clinical - Norfolk, Norfolk
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Children's Specialty Group - 3 Commercial Place, Norfolk
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Jun 12, 2026 · NCT05164172Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
- MedStar Health: Neurology at McLean, McLean
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 24, 2025 · NCT07301008From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.